Assessment of mucosal healing in inflammatory bowel disease: Review

Gastrointestinal Endoscopy

Volumn 82, Issue 2, 2015, Pages 246-255

  Dulai, Parambir S ^a,b   Levesque, Barrett G ^a,b   Feagan, Brian G ^b,c   D'Haens, Geert ^b,d   Sandborn, William J ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b ROBARTS RESEARCH INSTITUTE   (Canada)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSULE ENDOSCOPY; CLINICAL ASSESSMENT; CLINICAL PRACTICE; CLINICAL TRIAL (TOPIC); COMPARATIVE EFFECTIVENESS; CROHN DISEASE; DEVICE ASSISTED ENTEROSCOPY; DISEASE ACTIVITY; DISEASE MARKER; FEASIBILITY STUDY; GASTROINTESTINAL TRACT EXAMINATION; HISTOPATHOLOGY; HUMAN; INFLAMMATORY BOWEL DISEASE; INTESTINE BIOPSY; INTESTINE ENDOSCOPY; MAGNETIC RESONANCE ENTEROGRAPHY; MUCOSAL HEALING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REVIEW; SMALL INTESTINE CANCER; ULCER HEALING; COMPARATIVE STUDY; GASTROINTESTINAL ENDOSCOPY; INFLAMMATORY BOWEL DISEASES; INTESTINE MUCOSA; PATHOLOGY; PROCEDURES; SEVERITY OF ILLNESS INDEX; WOUND HEALING;

CAPSULE ENDOSCOPY; ENDOSCOPY, GASTROINTESTINAL; HUMANS; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; MAGNETIC RESONANCE IMAGING; SEVERITY OF ILLNESS INDEX; WOUND HEALING;

EID: 84937523961     PISSN: 00165107     EISSN: 10976779     Source Type: Journal    
DOI: 10.1016/j.gie.2015.03.1974     Document Type: Review

References (98)

1. C. Abraham, and J.H. Cho Inflammatory bowel disease N Engl J Med 361 2009 2066 2078
2. I. Ordas, L. Eckmann, M. Talamini, and et al. Ulcerative colitis Lancet 380 2012 1606 1619
3. D.C. Baumgart, and W.J. Sandborn Crohn's disease Lancet 380 2012 1590 1605
4. N. Williet, W.J. Sandborn, and L. Peyrin-Biroulet Patient-reported outcomes as primary end points in clinical trials of inflammatory bowel disease Clin Gastroenterol Hepatol 12 2014 1246 1256.e6
5. L. Peyrin-Biroulet, W. Reinisch, J.F. Colombel, and et al. Clinical disease activity, C-reactive protein normalisation and mucosal healing in Crohn's disease in the SONIC trial Gut 63 2014 88 95
6. Levesque BG, Sandborn WJ, Ruel J, et al. Converging goals of treatment for inflammatory bowel disease, from clinical trials and practice. Gastroenterology. Epub 2014 Aug 13.
7. G. D'Haens, W.J. Sandborn, B.G. Feagan, and et al. A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis Gastroenterology 132 2007 763 786
8. G.R. D'Haens, R. Fedorak, M. Lemann, and et al. Endpoints for clinical trials evaluating disease modification and structural damage in adults with Crohn's disease Inflamm Bowel Dis 15 2009 1599 1604
9. A. Walsh, R. Palmer, and S. Travis Mucosal healing as a target of therapy for colonic inflammatory bowel disease and methods to score disease activity Gastrointest Endosc Clin N Am 24 2014 367 378
10. W. Fries, A. Belvedere, and S. Vetrano Sealing the broken barrier in IBD: intestinal permeability, epithelial cells and junctions Curr Drug Targets 14 2013 1460 1470
11. M.F. Neurath, and S.P. Travis Mucosal healing in inflammatory bowel diseases: a systematic review Gut 61 2012 1619 1635
12. R. Khanna, G. Bouguen, B.G. Feagan, and et al. A systematic review of measurement of endoscopic disease activity and mucosal healing in Crohn's disease: recommendations for clinical trial design Inflamm Bowel Dis 20 2014 1850 1861
13. M.A. Samaan, M.H. Mosli, W.J. Sandborn, and et al. A systematic review of the measurement of endoscopic healing in ulcerative colitis clinical trials: recommendations and implications for future research Inflamm Bowel Dis 20 2014 1465 1471
14. S.Y. Salim, and J.D. Soderholm Importance of disrupted intestinal barrier in inflammatory bowel diseases Inflamm Bowel Dis 17 2011 362 381
15. P. Henderson, J.E. van Limbergen, J. Schwarze, and et al. Function of the intestinal epithelium and its dysregulation in inflammatory bowel disease Inflamm Bowel Dis 17 2011 382 395
16. K.F. Froslie, J. Jahnsen, B.A. Moum, and et al. Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort Gastroenterology 133 2007 412 422
17. S. Ardizzone, A. Cassinotti, P. Duca, and et al. Mucosal healing predicts late outcomes after the first course of corticosteroids for newly diagnosed ulcerative colitis Clin Gastroenterol Hepatol 9 2011 483 489.e3
18. J.F. Colombel, P. Rutgeerts, W. Reinisch, and et al. Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis Gastroenterology 141 2011 1194 1201
19. F. Schnitzler, H. Fidder, M. Ferrante, and et al. Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohn's disease Inflamm Bowel Dis 15 2009 1295 1301
20. P. Rutgeerts, R.H. Diamond, M. Bala, and et al. Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease Gastrointest Endosc 63 2006 433 442 quiz 464
21. M.D. Rutter, B.P. Saunders, K.H. Wilkinson, and et al. Cancer surveillance in longstanding ulcerative colitis: endoscopic appearances help predict cancer risk Gut 53 2004 1813 1816
22. F. Baert, L. Moortgat, G. Van Assche, and et al. Mucosal healing predicts sustained clinical remission in patients with early-stage Crohn's disease Gastroenterology 138 2010 463 468 quiz e10-1
23. I. Ordas, J. Rimola, S. Rodriguez, and et al. Accuracy of magnetic resonance enterography in assessing response to therapy and mucosal healing in patients with Crohn's disease Gastroenterology 146 2014 374 382.e1
24. M. Dave, and E.V. Loftus Jr. Mucosal healing in inflammatory bowel disease - a true paradigm of success? Gastroenterol Hepatol (NY) 8 2012 29 38
25. D.S. Fefferman, and R.J. Farrell Endoscopy in inflammatory bowel disease: indications, surveillance, and use in clinical practice Clin Gastroenterol Hepatol 3 2005 11 24
26. J.A. Leighton, B. Shen, T.H. Baron, and et al. ASGE guideline: endoscopy in the diagnosis and treatment of inflammatory bowel disease Gastrointest Endosc 63 2006 558 565
27. Bouguen G, Levesque BG, Feagan BG, et al. Treat to target: a proposed new paradigm for the management of Crohn's disease. Clin Gastroenterol Hepatol. Epub 2013 Sep 10.
28. G. Bouguen, B.G. Levesque, S. Pola, and et al. Endoscopic assessment and treating to target increase the likelihood of mucosal healing in patients with Crohn's disease Clin Gastroenterol Hepatol 12 2014 978 985
29. G. Bouguen, B.G. Levesque, S. Pola, and et al. Feasibility of endoscopic assessment and treating to target to achieve mucosal healing in ulcerative colitis Inflamm Bowel Dis 20 2014 231 239
30. C.A. Siegel, S.M. Marden, C. Kozlowski, and et al. Crohn's disease patients report their definitions of "rare" adverse events, remission and the importance of mucosal healing: a quantitative and qualitative study of what patients really think Gastroenterology 140 May, 2011 S-141
31. R. Makkar, and S. Bo Colonoscopic perforation in inflammatory bowel disease Gastroenterol Hepatol (NY) 9 2013 573 583
32. P.S. Dulai, E.S. Fisher, and R.I. Rothstein How may the transition to value-based payment influence gastroenterology: threat or opportunity? Clin Gastroenterol Hepatol 10 2012 609 611
33. G.R. Lichtenstein, D. Ramsey, and D.T. Rubin Randomised clinical trial: delayed-release oral mesalazine 4.8 g/day vs. 2.4 g/day in endoscopic mucosal healing - ASCEND I and II combined analysis Aliment Pharmacol Ther 33 2011 672 678
34. W.J. Sandborn, M.A. Kamm, G.R. Lichtenstein, and et al. MMX Multi Matrix System mesalazine for the induction of remission in patients with mild-to-moderate ulcerative colitis: a combined analysis of two randomized, double-blind, placebo-controlled trials Aliment Pharmacol Ther 26 2007 205 215
35. V. Gross, S. Bar-Meir, A. Lavy, and et al. Budesonide foam versus budesonide enema in active ulcerative proctitis and proctosigmoiditis Aliment Pharmacol Ther 23 2006 303 312
36. S. Ardizzone, G. Maconi, A. Russo, and et al. Randomised controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitis Gut 55 2006 47 53
37. H. Ogata, J. Kato, F. Hirai, and et al. Double-blind, placebo-controlled trial of oral tacrolimus (FK506) in the management of hospitalized patients with steroid-refractory ulcerative colitis Inflamm Bowel Dis 18 2012 803 808
38. W.J. Sandborn, B.G. Feagan, C. Marano, and et al. Subcutaneous golimumab maintains clinical response in patients with moderate-to-severe ulcerative colitis Gastroenterology 146 2014 96 109.e1
39. P. Rutgeerts, W.J. Sandborn, B.G. Feagan, and et al. Infliximab for induction and maintenance therapy for ulcerative colitis N Engl J Med 353 2005 2462 2476
40. W.J. Sandborn, G. van Assche, W. Reinisch, and et al. Adalimumab induces and maintains clinical remission in patients with moderate-to-severe ulcerative colitis Gastroenterology 142 2012 257 265 e1-3
41. W. Reinisch, W.J. Sandborn, D.W. Hommes, and et al. Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial Gut 60 2011 780 787
42. B.G. Feagan, P. Rutgeerts, B.E. Sands, and et al. Vedolizumab as induction and maintenance therapy for ulcerative colitis N Engl J Med 369 2013 699 710
43. R. Panaccione, S. Ghosh, S. Middleton, and et al. Combination therapy with infliximab and azathioprine is superior to monotherapy with either agent in ulcerative colitis Gastroenterology 146 2014 392 400.e3
44. R. Modigliani, J.Y. Mary, J.F. Simon, and et al. Clinical, biological, and endoscopic picture of attacks of Crohn's disease. Evolution on prednisolone [French]. Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives Gastroenterology 98 1990 811 818
45. G.J. Mantzaris, A. Christidou, M. Sfakianakis, and et al. Azathioprine is superior to budesonide in achieving and maintaining mucosal healing and histologic remission in steroid-dependent Crohn's disease Inflamm Bowel Dis 15 2009 375 382
46. P. Rutgeerts, G. Van Assche, W.J. Sandborn, and et al. Adalimumab induces and maintains mucosal healing in patients with Crohn's disease: data from the EXTEND trial Gastroenterology 142 2012 1102 1111.e2
47. J.F. Colombel, W.J. Sandborn, M. Allez, and et al. Association between plasma concentrations of certolizumab pegol and endoscopic outcomes of patients with Crohn's disease Clin Gastroenterol Hepatol 12 2014 423 431.e1
48. J.F. Colombel, W.J. Sandborn, W. Reinisch, and et al. Infliximab, azathioprine, or combination therapy for Crohn's disease N Engl J Med 362 2010 1383 1395
49. Feagan B. Enhanced algorithm for Crohn's treatment incorporating early combination therapy (REACT2). ClinicalTrials.gov. Available at: https://clinicaltrials.gov/ct2/show/NCT01698307. April 14, 2015.
50. A.J. Walsh, A. Ghosh, A.O. Brain, and et al. Comparing disease activity indices in ulcerative colitis J Crohns Colitis 8 2014 318 325
51. B.G. Feagan, W.J. Sandborn, G. D'Haens, and et al. The role of centralized reading of endoscopy in a randomized controlled trial of mesalamine for ulcerative colitis Gastroenterology 145 2013 149 157.e2
52. R.V. Bryant, S. Winer, S.P. Travis, and et al. Systematic review: histological remission in inflammatory bowel disease. Is 'complete' remission the new treatment paradigm? An IOIBD initiative J Crohns Colitis 8 2014 1582 1597
53. M.H. Mosli, B.G. Feagan, W.J. Sandborn, and et al. Histologic evaluation of ulcerative colitis: a systematic review of disease activity indices Inflamm Bowel Dis 20 2014 564 575
54. Mosli MH, Feagan BG, Zou G, et al. Reproducibility of histological assessments of disease activity in UC. Gut. Epub 2014 Oct 30.
55. G.E. Tontini, M. Vecchi, M.F. Neurath, and et al. Advanced endoscopic imaging techniques in Crohn's disease J Crohns Colitis 8 2014 261 269
56. G.E. Tontini, M. Vecchi, M.F. Neurath, and et al. Review article: newer optical and digital chromoendoscopy techniques vs. dye-based chromoendoscopy for diagnosis and surveillance in inflammatory bowel disease Aliment Pharmacol Ther 38 2013 1198 1208
57. I.E. Koutroubakis, G. Tsiolakidou, K. Karmiris, and et al. Role of angiogenesis in inflammatory bowel disease Inflamm Bowel Dis 12 2006 515 523
58. M. Pellise, M. Lopez-Ceron, C. Rodriguez de Miguel, and et al. Narrow-band imaging as an alternative to chromoendoscopy for the detection of dysplasia in long-standing inflammatory bowel disease: a prospective, randomized, crossover study Gastrointest Endosc 74 2011 840 848
59. S. Danese, G. Fiorino, E. Angelucci, and et al. Narrow-band imaging endoscopy to assess mucosal angiogenesis in inflammatory bowel disease: a pilot study World J Gastroenterol 16 2010 2396 2400
60. T. Kudo, T. Matsumoto, M. Esaki, and et al. Mucosal vascular pattern in ulcerative colitis: observations using narrow band imaging colonoscopy with special reference to histologic inflammation Int J Colorectal Dis 24 2009 495 501
61. H. Neumann, M. Vieth, C. Gunther, and et al. Virtual chromoendoscopy for prediction of severity and disease extent in patients with inflammatory bowel disease: a randomized controlled study Inflamm Bowel Dis 19 2013 1935 1942
62. V. Villanacci, E. Antonelli, K. Geboes, and et al. Histological healing in inflammatory bowel disease: a still unfulfilled promise World J Gastroenterol 19 2013 968 978
63. L. Peyrin-Biroulet, E.V. Loftus Jr., J.F. Colombel, and et al. The natural history of adult Crohn's disease in population-based cohorts Am J Gastroenterol 105 2010 289 297
64. P. Papay, A. Ignjatovic, K. Karmiris, and et al. Optimising monitoring in the management of Crohn's disease: a physician's perspective J Crohns Colitis 7 2013 653 669
65. Y. Qiu, R. Mao, B.L. Chen, and et al. Systematic review with meta-analysis: magnetic resonance enterography vs. computed tomography enterography for evaluating disease activity in small bowel Crohn's disease Aliment Pharmacol Ther 40 2014 134 146
66. L.E. Cipriano, B.G. Levesque, G.S. Zaric, and et al. Cost-effectiveness of imaging strategies to reduce radiation-induced cancer risk in Crohn's disease Inflamm Bowel Dis 18 2012 1240 1248
67. S.M. Madsen, H.S. Thomsen, P. Schlichting, and et al. Evaluation of treatment response in active Crohn's disease by low-field magnetic resonance imaging Abdom Imaging 24 1999 232 239
68. G. Van Assche, K.A. Herrmann, E. Louis, and et al. Effects of infliximab therapy on transmural lesions as assessed by magnetic resonance enteroclysis in patients with ileal Crohn's disease J Crohns Colitis 7 2013 950 957
69. J. Rimola, S. Rodriguez, O. Garcia-Bosch, and et al. Magnetic resonance for assessment of disease activity and severity in ileocolonic Crohn's disease Gut 58 2009 1113 1120
70. B.G. Levesque, L.E. Cipriano, S.L. Chang, and et al. Cost effectiveness of alternative imaging strategies for the diagnosis of small-bowel Crohn's disease Clin Gastroenterol Hepatol 8 2010 261 267 267.e1-4
71. S.L. Triester, J.A. Leighton, G.I. Leontiadis, and et al. A meta-analysis of the yield of capsule endoscopy compared to other diagnostic modalities in patients with non-stricturing small bowel Crohn's disease Am J Gastroenterol 101 2006 954 964
72. P.M. Dionisio, S.R. Gurudu, J.A. Leighton, and et al. Capsule endoscopy has a significantly higher diagnostic yield in patients with suspected and established small-bowel Crohn's disease: a meta-analysis Am J Gastroenterol 105 2010 1240 1248 quiz 1249
73. A. Efthymiou, N. Viazis, G. Mantzaris, and et al. Does clinical response correlate with mucosal healing in patients with Crohn's disease of the small bowel? A prospective, case-series study using wireless capsule endoscopy Inflamm Bowel Dis 14 2008 1542 1547
74. I. Shafran, P. Burgunder, and M. Kwa P-081 The use of serial wireless capsule endoscopy in treatment decisions to improve outcomes in small bowel Crohn's disease Inflam Bowel Dis 19 2013 S58
75. B. Hall, G. Holleran, J.L. Chin, and et al. A prospective 52 week mucosal healing assessment of small bowel Crohn's disease as detected by capsule endoscopy J Crohns Colitis 8 2014 1601 1609
76. B.J. Hall, G.E. Holleran, S.M. Smith, and et al. A prospective 12-week mucosal healing assessment of small bowel Crohn's disease as detected by capsule endoscopy Eur J Gastroenterol Hepatol 26 2014 1253 1259
77. M.E. Riccioni, R. Urgesi, R. Cianci, and et al. Colon capsule endoscopy: advantages, limitations and expectations. Which novelties? World J Gastrointest Endosc 4 2012 99 107
78. G.R. D'Haens, D. Franchimont, M. Lowenberg, and et al. Tu1531 Assessment of the performance of the colonic PillCam Pcce-2 in patients with active Crohn's disease: a pilot study [abstract] Gastrointest Endosc 79 2014 AB574
79. D. Hudesman, J. Mazurek, and A. Swaminath Capsule endoscopy in Crohn's disease: Are we seeing any better? World J Gastroenterol 20 2014 13044 13051
80. A.S. Cheifetz, A.A. Kornbluth, P. Legnani, and et al. The risk of retention of the capsule endoscope in patients with known or suspected Crohn's disease Am J Gastroenterol 101 2006 2218 2222
81. Z. Liao, R. Gao, C. Xu, and et al. Indications and detection, completion, and retention rates of small-bowel capsule endoscopy: a systematic review Gastrointest Endosc 71 2010 280 286
82. E. Niv, S. Fishman, H. Kachman, and et al. Sequential capsule endoscopy of the small bowel for follow-up of patients with known Crohn's disease J Crohns Colitis 8 2014 1616 1623
83. E. Rondonotti, J.M. Herrerias, M. Pennazio, and et al. Complications, limitations, and failures of capsule endoscopy: a review of 733 cases Gastrointest Endosc 62 2005 712 716 quiz 752-4
84. O. Atay, L. Mahajan, and M. Kay Risk of capsule endoscope retention in pediatric patients: a large single-center experience and review of the literature J Pediatr Gastroenterol Nutr 49 2009 Aug 196 201
85. C. Cahill, P.H. Gordon, A. Petrucci, and et al. Small bowel adenocarcinoma and Crohn's disease: Any further ahead than 50 years ago? World J Gastroenterol 20 2014 11486 11495
86. J.L. Goldstein, G.M. Eisen, B. Lewis, and et al. Small bowel mucosal injury is reduced in healthy subjects treated with celecoxib compared with ibuprofen plus omeprazole, as assessed by video capsule endoscopy Alim Pharmacol Therapeut 25 2007 1211 1222
87. L. Maiden, B. Thjodleifsson, A. Theodors, and et al. A quantitative analysis of NSAID-induced small bowel pathology by capsule enteroscopy Gastroenterology 128 2005 1172 1178
88. J.L. Goldstein, G.M. Eisen, B. Lewis, and et al. Video capsule endoscopy to prospectively assess small bowel injury with celecoxib, naproxen plus omeprazole, and placebo Clin Gastroenterol Hepatol 3 2005 133 141
89. D.Y. Graham, A.R. Opekun, F.F. Willingham, and et al. Visible small-intestinal mucosal injury in chronic NSAID users Clin Gastroenterol Hepatol 3 2005 55 59
90. R. Eliakim, and D. Carter Endoscopic assessment of the small bowel Dig Dis 31 2013 194 198
91. B.S. Lewis, G.M. Eisen, and S. Friedman A pooled analysis to evaluate results of capsule endoscopy trials Endoscopy 37 2005 960 965
92. A. Ross, S. Mehdizadeh, J. Tokar, and et al. Double balloon enteroscopy detects small bowel mass lesions missed by capsule endoscopy Dig Dis Sci 53 2008 2140 2143
93. G.D. Schwartz, and J.S. Barkin Small-bowel tumors detected by wireless capsule endoscopy Dig Dis Sci 52 2007 1026 1030
94. D.J. Cangemi, M.K. Patel, V. Gomez, and et al. Small bowel tumors discovered during double-balloon enteroscopy: analysis of a large prospectively collected single-center database J Clin Gastroenterol 47 2013 769 772
95. E.K. Wright, P. De Cruz, R. Gearry, and et al. Fecal biomarkers in the diagnosis and monitoring of Crohn's disease Inflamm Bowel Dis 20 2014 1668 1677
96. Z. Yang, N. Clark, and K.T. Park Effectiveness and cost-effectiveness of measuring fecal calprotectin in diagnosis of inflammatory bowel disease in adults and children Clin Gastroenterol Hepatol 12 2014 253 262.e2
97. G. D'Haens, M. Ferrante, S. Vermeire, and et al. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease Inflamm Bowel Dis 18 2012 2218 2224
98. J. Guardiola, T. Lobaton, L. Rodriguez-Alonso, and et al. Fecal level of calprotectin identifies histologic inflammation in patients with ulcerative colitis in clinical and endoscopic remission Clin Gastroenterol Hepatol 12 2014 1865 1870